Holzer Karen, Anderson Sandra D, Douglass Jo
Department of Allergy, Asthma and Clinical Immunology, Alfred Hospital and Monash University, Prahran, Australia.
J Allergy Clin Immunol. 2002 Sep;110(3):374-80. doi: 10.1067/mai.2002.127784.
There is a high prevalence of asthma and exercise-induced bronchoconstriction (EIB) in elite athletes when the diagnosis is based on symptoms and medication use. Objective measurements are now required by some sporting bodies to support a diagnosis of asthma or EIB to justify use of beta-agonists. Such measurements could include bronchial provocation with methacholine, with eucapnic voluntary hyperpnea (EVH) of dry air (a surrogate for exercise), or both.
The aim of the study was to investigate the relationship between asthma symptoms and responses to methacholine and the EVH challenge in a group of unselected elite summer-sport athletes. The outcome would be to inform practitioners of a suitable objective approach to identifying those with asthma and EIB.
Fifty elite summer-sport athletes with or without asthma were recruited from sporting teams and sports medicine centers throughout Melbourne, Australia. All subjects completed a respiratory questionnaire and, on separate days, underwent a bronchoprovocation challenge test with methacholine and EVH.
Forty-two subjects reported one or more respiratory symptoms in the past year, 9 had positive methacholine challenge results (mean PD(20) of 1.69 +/- 2.05 micromol), and 25 had positive EVH challenge results (mean fall in FEV(1) of 25.4% +/- 15%). Although all subjects with positive methacholine challenge results had positive EVH challenge results, methacholine had a negative predictive value of only 61% and a sensitivity of 36% for identifying those responsive to EVH.
These findings suggest that the pathogenesis of EIB in elite athletes might be different from that of asthma, and as such, neither symptoms nor the methacholine challenge test should be used exclusively for identifying EIB.
当根据症状和药物使用情况进行诊断时,精英运动员中哮喘和运动诱发支气管收缩(EIB)的患病率很高。现在一些体育机构要求进行客观测量,以支持哮喘或EIB的诊断,从而证明使用β-激动剂的合理性。此类测量可能包括用乙酰甲胆碱进行支气管激发试验、对干燥空气进行等二氧化碳通气过度(EVH)(作为运动的替代方法),或两者兼用。
本研究的目的是调查一组未经挑选的精英夏季运动项目运动员中哮喘症状与对乙酰甲胆碱和EVH激发试验反应之间的关系。研究结果将为从业者提供一种合适的客观方法,以识别患有哮喘和EIB的运动员。
从澳大利亚墨尔本的运动队和运动医学中心招募了50名有或无哮喘的精英夏季运动项目运动员。所有受试者均完成一份呼吸问卷,并在不同日期分别接受乙酰甲胆碱和EVH支气管激发试验。
42名受试者在过去一年中报告了一种或多种呼吸道症状,9名受试者乙酰甲胆碱激发试验结果为阳性(平均PD20为1.69±2.05微摩尔),25名受试者EVH激发试验结果为阳性(平均第一秒用力呼气容积(FEV1)下降25.4%±15%)。虽然所有乙酰甲胆碱激发试验结果为阳性的受试者EVH激发试验结果也为阳性,但乙酰甲胆碱对识别对EVH有反应者的阴性预测值仅为61%,敏感性为36%。
这些发现表明,精英运动员中EIB的发病机制可能与哮喘不同,因此,症状和乙酰甲胆碱激发试验均不应单独用于识别EIB。